Digital-first GLP-1 program delivers 16.1 kg average weight loss across 8,000+ women

EricTopol · x · 2026-10-16

A real-world observational study published in Nature Medicine reports outcomes for 8,127 women starting GLP-1 receptor agonist therapy (99.8% tirzepatide) through a structured digital program in the UK, featuring mandatory biochemical monitoring, weekly video-supported follow-up, and clinician-guided dose titration.

Original post →

More from Apps

Apps channel →